Doctor Maria Tafelmeier

University Hospital Regensburg, Regensburg (Germany)

Follow

Contributor content

Sacubitril/valsartan for treatment of symptomatic non-obstructive hypertrophic cardiomyopathy: a randomised, controlled, phase II clinical trial (SILICOFCM)

Presentation

Sacubitril/valsartan for treatment of symptomatic non-obstructive hypertrophic cardiomyopathy: a randomised, controlled, phase II clinical trial (SILICOFCM)

ESC 365 is supported by

novartis

Explore sponsored resources